Search research articles
Contact Us
Filters
Showing results (61-70 of 88) with videos related to
Page
of 9
Sort By:
British Journal of Cancer
|
April 1, 2010
Chemoradiation for the treatment of epidermoid anal cancer: 13-year follow-up of the first randomised UKCCCR Anal Cancer Trial (ACT I)
J Northover, R Glynne-Jones, D Sebag-Montefiore, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 11, 2014
Chronicle: results of a randomised phase III trial in locally advanced rectal cancer after neoadjuvant chemoradiation randomising postoperative adjuvant capecitabine plus oxaliplatin (XELOX) versus control
R Glynne-Jones, N Counsell, P Quirke, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))
|
June 20, 2021
Body Composition and Dose-limiting Toxicity in Colorectal Cancer Chemotherapy Treatment; a Systematic Review of the Literature. Could Muscle Mass be the New Body Surface Area in Chemotherapy Dosing?
I Drami, E T Pring, L Gould, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 3, 1999
Effect of hepatic dysfunction due to liver metastases on the pharmacokinetics of capecitabine and its metabolites
C Twelves, R Glynne-Jones, J Cassidy, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))
|
August 15, 2000
Preoperative ECF chemotherapy in gastro-oesophageal adenocarcinoma
J I Geh, R Glynne-Jones, Q S Kwok, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))
|
November 5, 2016
Initial Results from the Royal College of Radiologists' UK National Audit of Anal Cancer Radiotherapy 2015
R Muirhead, K Drinkwater, S M O'Cathail, et al.
The British Journal of Surgery
|
March 21, 2016
Influence of body composition profile on outcomes following colorectal cancer surgery
G Malietzis, A C Currie, T Athanasiou, et al.
European Journal of Cancer (Oxford, England : 1990)
|
February 29, 2020
UK national cohort of anal cancer treated with intensity-modulated radiotherapy: One-year oncological and patient-reported outcomes
A Gilbert, K Drinkwater, L McParland, et al.
The British Journal of Surgery
|
May 5, 2006
Dynamic contrast-enhanced magnetic resonance imaging is a poor measure of rectal cancer angiogenesis
G Atkin, N J Taylor, F M Daley, et al.
Critical Reviews in Oncology/Hematology
|
August 12, 2018
Ablative stereotactic radiotherapy for oligometastatic colorectal cancer: Systematic review
J Kobiela, P Spychalski, G Marvaso, et al.
Page
of 9
Search research articles
Search
Showing results (61-70 of 88) with videos related to
Sort By:
Page
of 9
British Journal of Cancer
|
April 1, 2010
Chemoradiation for the treatment of epidermoid anal cancer: 13-year follow-up of the first randomised UKCCCR Anal Cancer Trial (ACT I)
J Northover, R Glynne-Jones, D Sebag-Montefiore, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 11, 2014
Chronicle: results of a randomised phase III trial in locally advanced rectal cancer after neoadjuvant chemoradiation randomising postoperative adjuvant capecitabine plus oxaliplatin (XELOX) versus control
R Glynne-Jones, N Counsell, P Quirke, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))
|
June 20, 2021
Body Composition and Dose-limiting Toxicity in Colorectal Cancer Chemotherapy Treatment; a Systematic Review of the Literature. Could Muscle Mass be the New Body Surface Area in Chemotherapy Dosing?
I Drami, E T Pring, L Gould, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 3, 1999
Effect of hepatic dysfunction due to liver metastases on the pharmacokinetics of capecitabine and its metabolites
C Twelves, R Glynne-Jones, J Cassidy, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))
|
August 15, 2000
Preoperative ECF chemotherapy in gastro-oesophageal adenocarcinoma
J I Geh, R Glynne-Jones, Q S Kwok, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))
|
November 5, 2016
Initial Results from the Royal College of Radiologists' UK National Audit of Anal Cancer Radiotherapy 2015
R Muirhead, K Drinkwater, S M O'Cathail, et al.
The British Journal of Surgery
|
March 21, 2016
Influence of body composition profile on outcomes following colorectal cancer surgery
G Malietzis, A C Currie, T Athanasiou, et al.
European Journal of Cancer (Oxford, England : 1990)
|
February 29, 2020
UK national cohort of anal cancer treated with intensity-modulated radiotherapy: One-year oncological and patient-reported outcomes
A Gilbert, K Drinkwater, L McParland, et al.
The British Journal of Surgery
|
May 5, 2006
Dynamic contrast-enhanced magnetic resonance imaging is a poor measure of rectal cancer angiogenesis
G Atkin, N J Taylor, F M Daley, et al.
Critical Reviews in Oncology/Hematology
|
August 12, 2018
Ablative stereotactic radiotherapy for oligometastatic colorectal cancer: Systematic review
J Kobiela, P Spychalski, G Marvaso, et al.
Page
of 9